Purification of avian influenza virus (H9N2) from allantoic fluidby size-exclusion chromatography

Purification of avian influenza virus (H9N2) from allantoic fluidby size-exclusion chromatography

Avian influenza viruses represent a rising threat of pandemic influenza. Allantoic fluid including influenza virus H9N2 was run on downstream processing to purify the virus. To do this, allantoic fluid was clarified and concentrated. It was applied to size exclusion chromatography. Different parameters such as ovalbumin, protein content, and hemagglutinin activity were determined to confirm the purity. The results may suggest that this method is quite efficient for achieving a purified H9N2 influenza virus and further reveal that size-exclusion chromatography is a practical method for purifying avian influenza viruses. In conclusion, this procedure can be used in vaccine production and antiserum preparation as an alternative to traditional methods and also can be considered in the purifying of other viruses when there is no facility of ultracentrifuge or zonal centrifuge.

___

  • 1. Lamb RA, Krug RM. Orthomyxoviridae. The viruses and their replication. In: Knipe DM, Howley PM, Chanock RM, Melnick JL, Momath TP, Roizman S, editors. Fields Virology. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2001. pp. 1487–1532.
  • 2. Lee CW, Saif YM. Avian influenza virus. Comp Immunol Microb 2009; 32: 301–310.
  • 3. Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA et al. A distinct lineage of influenza A virus from bats. P Natl Acad Sci USA 2012; 109: 4269–4274.
  • 4. Alexander DJ. A review of avian influenza in different bird species. Vet Microbiol 2000; 74: 3–13.
  • 5. Vasfi-Marandi M, Bozorgmehrifard MH. Isolation of H9N2 subtype of avian Influenza viruses during an out-break in chickens in Iran. Iran Biomed J 2002; 6: 13–17.
  • 6. Alizadeh E, Kheiri MT, Bashar R, Tabatabaeian M, Hosseini SM. Avian influenza (H9N2) among poultry workers in Iran. Iran J Microbiol 2009; 1: 3–6.
  • 7. Guo P, El-Gohary Y, Prasadan K, Shiota C, Xiao X, Wiersch J, Paredes J, Tulachan S, Gittes GK. Rapid and simplified purification of recombinant adeno-associated virus. J Virol Methods 2012; 183: 139–146.
  • 8. Hutchinson E, Fodor E. Purification of influenza virions by haemadsorption and ultracentrifugation. Protocol Exchange 2014; 2014: 10.1038.
  • 9. Kalbfuss B, Wolff M, Morenweiser R, Reichl U. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng 2007; 96: 932–944.
  • 10. Blanche F, Cameron B, Barbot A, Ferrero L, Guillemin T, Guyot S, Somarriba S, Bisch D. An improved anion-exchange HPLC method for the detection and purification of adenoviral particles. Gene Ther 2000; 7: 1055–1062.
  • 11. Heyward JT, Klimas RA, Stapp MD, Obijeski JF. The rapid concentration and purification of influenza virus from allantoic fluid. Arch Virol 1977; 55: 107–119.
  • 12. Ebrahimi MM, Moghaddampour M, Tavassoli A, Shahsavandi S. Vaccination of chicks with experimental Newcastle disease and avian influenza oil-emulsion vaccines by in ovo inoculation. Archives of Razi Institute 2000; 51: 15–25.
  • 13. Assembly of Delegates of the OIE. Avian Influenza. Paris, France: OIE; 2015.
  • 14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254.
  • 15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.
  • 16. Nazari Shirvan A, Moradi M, Aminian M, Madani R. Preparation of neuraminidase-specific antiserum from the H9N2 subtype of avian influenza virus. Turk J Vet Anim Sci 2007; 31: 219–223.
  • 17. Reimer CB, Baker RS, van Frank RM, Newlin TE, Cline GB, Anderson NG. Purification of large quantities of influenza virus by density gradient centrifugation. J Virol 1967; 1: 1207–1216.
  • 18. Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G. Influenza virus-like particles comprised of the HA, NA,and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005; 23: 5751–5759.
  • 19. Loa CC, Lin TL, Wu CC, Bryan TA, Thacker HL, Hooper T, Schrader D. Purification of turkey coronavirus by Sephacryl size-exclusion chromatography. J Virol Methods 2002; 104: 187–194.
  • 20. Nayak DP, Lehmann S, Reichel U. Downstream processing of MDCK cell-derived equine influenza virus. J Chromatogr B 2005; 823: 75–81.